search
Back to results

Public Support for COVID-19 Test Allocation

Primary Purpose

Health Equity, COVID-19

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
First Come, First Served
Random
Disadvantaged Priority & Random
Sponsored by
University of Pennsylvania
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Health Equity focused on measuring Allocation of Healthcare Resources

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Aged 18 years old or older, United States resident

Exclusion Criteria:

  • None

Sites / Locations

  • Harris Insights & Analytics

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

First Come, First Served

Random

Disadvantaged Priority & Random

Arm Description

Respondents will view the following description: "The US government will make 500 million COVID-19 home tests available for free. US residents can ask for tests by entering their home address in a website. It is likely that more people will want tests than will be available. How should the government decide who will receive tests, when there are not enough for all who want them? One plan that is being considered is this one:" Below this statement, respondents will view the "First Come, First Served" plan description.

Respondents will view the following description: "The US government will make 500 million COVID-19 home tests available for free. US residents can ask for tests by entering their home address in a website. It is likely that more people will want tests than will be available. How should the government decide who will receive tests, when there are not enough for all who want them? One plan that is being considered is this one:" Below this statement, respondents will view the "Random" plan description.

Respondents will view the following description: "The US government will make 500 million COVID-19 home tests available for free. US residents can ask for tests by entering their home address in a website. It is likely that more people will want tests than will be available. How should the government decide who will receive tests, when there are not enough for all who want them? One plan that is being considered is this one:" Below this statement, respondents will view the "Disadvantaged Priority & Random" plan description.

Outcomes

Primary Outcome Measures

Support for allocation plan
Self-reported degree of support for the plan, measured on a 5-point Likert scale ("strongly oppose" to "strongly support") that will be collapsed into 3 response categories ("oppose," "neutral," and "support") for analysis.

Secondary Outcome Measures

Household-level test allocation preference
Preferred way of sending tests to households, measured as a binary choice between a fixed or variable (based on household size) number of tests per household.
Tests allocated to disadvantaged areas
Self-reported percentage of tests wanted to be sent to disadvantaged areas, measured as a continuous variable on a slider from 0% to 100% with increments of 0.1%. This outcome will only be measured for respondents in the "Disadvantaged Priority & Random" condition.

Full Information

First Posted
January 7, 2022
Last Updated
January 7, 2022
Sponsor
University of Pennsylvania
search

1. Study Identification

Unique Protocol Identification Number
NCT05185687
Brief Title
Public Support for COVID-19 Test Allocation
Official Title
Race, Status, Vaccines, Tests, and Place: Public Attitudes and Support for Equitable COVID-19 Vaccine and Test Allocation
Study Type
Interventional

2. Study Status

Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
January 4, 2022 (Actual)
Primary Completion Date
January 6, 2022 (Actual)
Study Completion Date
January 6, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pennsylvania

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
In a randomized survey experiment, investigators will assess public support or opposition towards one of three potential government plans for allocating at-home coronavirus disease 2019 (COVID-19) tests to United States residents: 1) first come, first served; 2) a random draw; or 3) a random draw with 20% of tests reserved for disadvantaged areas. Investigators will also examine public attitudes surrounding other logistical and equity-related aspects of these allocation plans.
Detailed Description
Complementing other efforts to increase access to COVID-19 testing in the United States, the federal government recently announced the purchase of 500,000,000 at home COVID-19 to be distributed for free "to Americans that want them". A central logistical element in matching supply with demand will be a website, on which people will register their interest in getting tests delivered to their home address. However, it is still unclear how supply will be matched with demand. Three main candidate options are first come, first served (FCFS), in which people are sent tests in the order in which they make requests; a random draw, such as a lottery; or a combination of a random draw with a guaranteed reserved amount for more disadvantaged populations. FCFS is a widely known and practiced rationing principle, but it has shown to exacerbate inequities in, for example, the allocation of vaccine appointments. Random draws can mitigate this impact, but, in the present context, might be insufficiently sensitive to the fact that not everyone has internet access, and that the need for testing is greater among more disadvantaged communities. Combining a lottery with a disadvantage reserve system using measures such as the CDC's Social Vulnerability Index is a practical way of promoting equity, and it was already used by the majority of US states in allocating vaccines. The main objective of this study is to assess public support for each of these three allocation plans and describe differences by demographic characteristics. Investigators will also assess public attitudes toward specific details of these allocation plans. The study, which is expected to take approximately 5 minutes to complete, will be administered as part of an omnibus online survey.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Health Equity, COVID-19
Keywords
Allocation of Healthcare Resources

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
2019 (Actual)

8. Arms, Groups, and Interventions

Arm Title
First Come, First Served
Arm Type
Experimental
Arm Description
Respondents will view the following description: "The US government will make 500 million COVID-19 home tests available for free. US residents can ask for tests by entering their home address in a website. It is likely that more people will want tests than will be available. How should the government decide who will receive tests, when there are not enough for all who want them? One plan that is being considered is this one:" Below this statement, respondents will view the "First Come, First Served" plan description.
Arm Title
Random
Arm Type
Experimental
Arm Description
Respondents will view the following description: "The US government will make 500 million COVID-19 home tests available for free. US residents can ask for tests by entering their home address in a website. It is likely that more people will want tests than will be available. How should the government decide who will receive tests, when there are not enough for all who want them? One plan that is being considered is this one:" Below this statement, respondents will view the "Random" plan description.
Arm Title
Disadvantaged Priority & Random
Arm Type
Experimental
Arm Description
Respondents will view the following description: "The US government will make 500 million COVID-19 home tests available for free. US residents can ask for tests by entering their home address in a website. It is likely that more people will want tests than will be available. How should the government decide who will receive tests, when there are not enough for all who want them? One plan that is being considered is this one:" Below this statement, respondents will view the "Disadvantaged Priority & Random" plan description.
Intervention Type
Behavioral
Intervention Name(s)
First Come, First Served
Intervention Description
Respondents will view the following description of the plan: "Tests will be sent out in the order they are requested. People who request tests the quickest will get them first, no matter where they live. People who request tests later may not get any. This strategy is also known as 'First Come, First Served.'"
Intervention Type
Behavioral
Intervention Name(s)
Random
Intervention Description
Respondents will view the following description of the plan: "People who request tests will be entered into a random drawing, like a sweepstakes or lottery. Everyone who is in the drawing has the same chance of getting tests, no matter where they live, but some people may not get any tests."
Intervention Type
Behavioral
Intervention Name(s)
Disadvantaged Priority & Random
Intervention Description
Respondents will view the following description of the plan: "Because COVID-19 has hit people living in disadvantaged areas of the country harder, a proportion of tests will be sent exclusively to people in these zip codes. Planners will allocate 80% of the tests using a random drawing, like a sweepstakes or lottery. Everyone who is in the drawing has the same chance of getting tests, no matter where they live. The remaining 20% are set aside exclusively for the most disadvantaged areas, again allocated with a random drawing. Some people may not get any tests. But people living in disadvantaged areas are more likely to get them."
Primary Outcome Measure Information:
Title
Support for allocation plan
Description
Self-reported degree of support for the plan, measured on a 5-point Likert scale ("strongly oppose" to "strongly support") that will be collapsed into 3 response categories ("oppose," "neutral," and "support") for analysis.
Time Frame
5 minutes
Secondary Outcome Measure Information:
Title
Household-level test allocation preference
Description
Preferred way of sending tests to households, measured as a binary choice between a fixed or variable (based on household size) number of tests per household.
Time Frame
5 minutes
Title
Tests allocated to disadvantaged areas
Description
Self-reported percentage of tests wanted to be sent to disadvantaged areas, measured as a continuous variable on a slider from 0% to 100% with increments of 0.1%. This outcome will only be measured for respondents in the "Disadvantaged Priority & Random" condition.
Time Frame
5 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Aged 18 years old or older, United States resident Exclusion Criteria: None
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alison M Buttenheim, PhD, MBA
Organizational Affiliation
University of Pennsylvania
Official's Role
Principal Investigator
Facility Information:
Facility Name
Harris Insights & Analytics
City
Washington
State/Province
District of Columbia
ZIP/Postal Code
20006
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided
IPD Sharing Plan Description
Only de-identified individual participant data will be shared by Harris Insights & Analytics to the research team. Each participant will have a unique identifier to protect their confidentiality. Only authorized research personnel will have access to the data which will be maintained on encrypted hard-drives. Individual participant data may be made available to other researchers in an open-access repository.

Learn more about this trial

Public Support for COVID-19 Test Allocation

We'll reach out to this number within 24 hrs